Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Vaccine|January 28, 2003
Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccineAlan Coulter, Rodney Harris, Roslyn Davis, et al.Vaccine|April 17, 2009
Single dose intranasal immunization with ISCOMATRIX vaccines to elicit antibody-mediated clearance of influenza virus requires delivery to the lower respiratory tractMegan T Sanders, Georgia Deliyannis, Martin J Pearse, et al.Human Vaccines|February 28, 2009
Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX vaccine: a phase I study in healthy volunteersDebbie Drane, Eugene Maraskovsky, Rebecca Gibson, et al.Vaccine|May 27, 2004
ISCOM based vaccines for cancer immunotherapyAleksandra Lenarczyk, Thuy T T Le, Debbie Drane, et al.Vaccine|April 3, 2012
Control of pandemic (H1N1) 2009 influenza virus infection of ferret lungs by non-adjuvant-containing pandemic and seasonal vaccinesSteven Rockman, Deborah J Middleton, Martin J Pearse, et al.Vaccine|August 19, 2004
ISCOMATRIX adjuvant: an adjuvant suitable for use in anticancer vaccinesTrina J Stewart, Debbie Drane, Jim Malliaros, et al.Vaccine|September 15, 2004
Association of antigens to ISCOMATRIX adjuvant using metal chelation leads to improved CTL responsesJim Malliaros, Charles Quinn, Frances H Arnold, et al.Infection and Immunity|November 21, 2007
CD8+ T cells are associated with severe gastritis in Helicobacter pylori-infected mice in the absence of CD4+ T cellsMai Ping Tan, John Pedersen, Yifan Zhan, et al.Human Vaccines & Immunotherapeutics|February 19, 2015
ISCOMATRIX™ adjuvant reduces mucosal tolerance for effective pulmonary vaccination against influenzaAndrea A Timothy, Ana Tokanovic, Kenneth J Snibson, et al.Blood|November 18, 2004
Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen deliveryMax Schnurr, Qiyuan Chen, Amanda Shin, et al.Pageof 4